IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach

Por Denti, Paolo, Bertoldo, Alessandra, Vicini, Paolo, Cobelli, Claudio
Publicado em 2010

Response to “Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy”

Por de Kock, Miné, Tarning, Joel, Barnes, Karen I., Denti, Paolo
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)

Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin

Por Zhang, Chao, Denti, Paolo, Decloedt, Eric H, Ren, Yuan, Karlsson, Mats O, McIlleron, Helen
Publicado em 2013

Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Por Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2015)

Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Por Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2016)

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis

Por Chirehwa, Maxwell T., McIlleron, Helen, Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2017)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

Por Rockwood, Neesha, Meintjes, Graeme, Chirehwa, Maxwell, Wiesner, Lubbe, McIlleron, Helen, Wilkinson, Robert J., Denti, Paolo
Publicado no Antimicrob Agents Chemother (2016)

Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicin

Por Zhang, Chao, Denti, Paolo, Decloedt, Eric, Maartens, Gary, Karlsson, Mats O, Simonsson, Ulrika S H, McIlleron, Helen
Publicado em 2012

Characterizing multisegment foot kinematics during gait in diabetic foot patients

Por Sawacha, Zimi, Cristoferi, Giuseppe, Guarneri, Gabriella, Corazza, Stefano, Donà, Giulia, Denti, Paolo, Facchinetti, Andrea, Avogaro, Angelo, Cobelli, Claudio
Publicado em 2009

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children

Por Zhang, Chao, Mcllleron, Helen, Ren, Yuan, van der Walt, Jan-Stefan, Karlsson, Mats O, Simonsson, Ulrika SH, Denti, Paolo
Publicado em 2012

A Time-to-Event Pharmacodynamic Model Describing Treatment Response in Patients with Pulmonary Tuberculosis Using Days to Positivity in Automated Liquid Mycobacterial Culture

Por Chigutsa, Emmanuel, Patel, Kashyap, Denti, Paolo, Visser, Marianne, Maartens, Gary, Kirkpatrick, Carl M. J., McIlleron, Helen, Karlsson, Mats O.
Publicado em 2013

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis

Por Rockwood, Neesha, Pasipanodya, Jotam G., Denti, Paolo, Sirgel, Frederick, Lesosky, Maia, Gumbo, Tawanda, Meintjes, Graeme, McIlleron, Helen, Wilkinson, Robert J.
Publicado no Clin Infect Dis (2017)

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

Por McIlleron, Helen, Rustomjee, Roxana, Vahedi, Mahnaz, Mthiyane, Thuli, Denti, Paolo, Connolly, Catherine, Rida, Wasima, Pym, Alexander, Smith, Peter J., Onyebujoh, Philip C.
Publicado em 2012

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics

Por Svensson, Elin, van der Walt, Jan-Stefan, Barnes, Karen I, Cohen, Karen, Kredo, Tamara, Huitema, Alwin, Nachega, Jean B, Karlsson, Mats O, Denti, Paolo
Publicado em 2012

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets

Por BIENCZAK, Andrzej, DENTI, Paolo, Adrian, COOK, WIESNER, Lubbe, MULENGA, Veronica, KITYO, Cissy, KEKITIINWA, Addy, GIBB, Diana M., BURGER, David, WALKER, A. Sarah, MCILLERON, Helen
Publicado no AIDS (2017)

Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa

Por Denti, Paolo, Martinson, Neil, Cohn, Silvia, Mashabela, Fildah, Hoffmann, Jennifer, Msandiwa, Reginah, Castel, Sandra, Wiesner, Lubbe, Chaisson, Richard E., McIlleron, Helen, Dooley, Kelly E.
Publicado no Antimicrob Agents Chemother (2016)

Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children

Por Bienczak, Andrzej, Denti, Paolo, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Gibb, Diana M., Burger, David, Walker, A. Sarah, McIlleron, Helen
Publicado no J Acquir Immune Defic Syndr (2016)

The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals

Por DECLOEDT, Eric H, MWANSA-KAMBAFWILE, Judith, VAN DER WALT, Jan-Stefan, MCILLERON, Helen, DENTI, Paolo, SMITH, Peter, WIESNER, Lubbe, RANGAKA, Molebogeng, WILKINSON, Robert J, MAARTENS, Gary
Publicado em 2013

Treatment failure, drug resistance, and CD4 T-cell count decline among postpartum women on antiretroviral therapy in South Africa

Por Hoffmann, Christopher J, Cohn, Silvia, Mashabela, Fildah, Hoffmann, Jennifer D, McIlleron, Helen, Denti, Paolo, Haas, David, Dooley, Kelly E, Martinson, Neil A, Chaisson, Richard E
Publicado no J Acquir Immune Defic Syndr (2016)

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

Por Naidoo, Anushka, Ramsuran, Veron, Chirehwa, Maxwell, Denti, Paolo, McIlleron, Helen, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Singh, Ravesh, Ngcapu, Sinaye, Chaudhry, Mamoonah, Pepper, Michael S, Padayatchi, Nesri
Publicado no Pharmacogenomics (2018)